Jaguar Animal Health is a biotechnology business based in the US. Jaguar Animal Health shares (JAGX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.98 – a decrease of 5.78% over the previous week. Jaguar Animal Health employs 49 staff and has a trailing 12-month revenue of around $10.2 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.98 |
|---|---|
| 52-week range | $0.90 - $30.84 |
| 50-day moving average | $1.14 |
| 200-day moving average | $4.38 |
| Wall St. target price | $14.50 |
| PE ratio | 0.2171 |
| Dividend yield | N/A |
| Earnings per share (TTM) | $4.79 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.97 from 2024-11-19
| 1 week (2024-11-15) | 1.04% |
|---|---|
| 1 month (2024-10-22) | -17.09% |
| 3 months (2024-08-22) | -21.14% |
| 6 months (2024-05-22) | 657.81% |
| 1 year (2023-11-22) | 182.80% |
|---|---|
| 2 years (2022-11-22) | -99.82% |
| 3 years (2021-11-22) | 6210 |
| 5 years (2019-11-22) | 7897.5 |
Valuing Jaguar Animal Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Jaguar Animal Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Jaguar Animal Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 0x. In other words, Jaguar Animal Health shares trade at around 0x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
| Revenue TTM | $10.2 million |
|---|---|
| Gross profit TTM | $2 million |
| Return on assets TTM | -34.53% |
| Return on equity TTM | -290.94% |
| Profit margin | 0% |
| Book value | $2.16 |
| Market Capitalization | $9.6 million |
TTM: trailing 12 months
We're not expecting Jaguar Animal Health to pay a dividend over the next 12 months.
Jaguar Animal Health's shares were split on a 1:60 basis on 22 May 2024 . So if you had owned 60 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Jaguar Animal Health shares – just the quantity. However, indirectly, the new 5900% higher share price could have impacted the market appetite for Jaguar Animal Health shares which in turn could have impacted Jaguar Animal Health's share price.
Over the last 12 months, Jaguar Animal Health's shares have ranged in value from as little as $0.9 up to $30.84. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Jaguar Animal Health's is 0.883. This would suggest that Jaguar Animal Health's shares are less volatile than average (for this exchange).
Jaguar Health, Inc. , a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products. The company's products include Mytesi, an anti-secretory antidiarrheal drug for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy; and Canalevia-CA1, a prescription drug product for chemotherapy-induced diarrhea in dogs. It is also developing Crofelemer, an anti-secretory antidiarrheal drug, which is in Phase 3 clinical trial for or prophylaxis of diarrhea in adult cancer patients, and to address rare/orphan disease indications, including short bowel syndrome with intestinal failure and/or congenital diarrheal disorders; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, the company is developing NP-300, a second-generation antidiarrheal drug for symptomatic relief and treatment of moderate-to-severe diarrhea.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.